Cortical nonenhancing tumor infiltration: a predictive imaging biomarker for IDH-mutant glioma
The CONTIN sign was a robust imaging biomarker for identifying IDH mutation status in diffuse glioma, particularly for those with contrast enhancement. Preoperative knowledge of IDH mutation status can enhance patient counseling and inform treatment decision-making.
Authors
- S Zhang
- S. Y. Tong (ORCID: https://orcid.org/0000-0003-3501-0455)
- Mingxiao Li (ORCID: https://orcid.org/0000-0002-4150-3080)
- Haihui Jiang (ORCID: https://orcid.org/0000-0002-8114-9741)
- Qingyun Ren (ORCID: https://orcid.org/0000-0003-0000-0417)
- Ming Li (ORCID: https://orcid.org/0000-0002-8427-605X)
- Xiaokang Zhang (ORCID: https://orcid.org/0000-0003-4684-317X)
- Xiaohui Ren (ORCID: https://orcid.org/0000-0001-7376-1191)
- Haoyi Li (ORCID: https://orcid.org/0000-0002-0583-3314)
- Yong Cui (ORCID: https://orcid.org/0000-0002-8613-010X)
- Song Lin (ORCID: https://orcid.org/0000-0002-1760-1887)
- Xijie Wang (ORCID: https://orcid.org/0000-0002-2035-4311)
- A. Liu
Institutions
- Capital Medical University (CN)
- Peking University (CN)
- China-Japan Friendship Hospital (CN)
- Beijing Tian Tan Hospital (CN)
- Chinese Institute for Brain Research (CN)
- Peking University Third Hospital (CN)
Publication Details
- Journal
- Journal of neurosurgery
- Published
- 2025-04-05
- DOI
- https://doi.org/10.3171/2024.11.jns242017
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00